Basic info
Industry
biotechnology research
Sectors
Research and Development
AML
In-licensing
Biotechnology
autoimmune
Targeted small molecules
IBD
Pharmaceutical
lupus
rheumatoid arthritis
Partnering
Addressing unmet medical needs
prostate cancer
inflammation
psoriasis
lupus nephritis
Medical
T-cell lymphoma
Life Science
Cancer
B-cell malignancies
Date founded
2012
Funding rounds raised
Total raised
$585K
from 2 investors over 2 rounds
I
Inflection Biosciences Ltd raised $82K on January 1, 2019
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)
I
Inflection Biosciences Ltd raised $585K on June 1, 2013
Investors: Enterprise Ireland